Relative risk reduction

The relative risk reduction is the proportionate reduction in risk between the drug under investigation and a placebo or comparator drug. If treatment A results in 5/1000 CVD events per year and treatment B results in 10/1000 CVD events per year, the relative risk reduction is 5/10 =50%.